Your browser doesn't support javascript.
loading
[13C]-galactose breath test in a patient with galactokinase deficiency and spastic diparesis.
Ficicioglu, Can; Demirbas, Didem; Derks, Britt; Pai, G Shashidhar; Timson, David J; Rubio-Gozalbo, Maria Estela; Berry, Gerard T.
Afiliação
  • Ficicioglu C; Department of Pediatrics, Section of Biochemical Genetics The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine Philadelphia Pennsylvania USA.
  • Demirbas D; Division of Genetics and Genomics, The Manton Center for Orphan Disease Research Boston Children's Hospital, Harvard Medical School Boston Massachusetts USA.
  • Derks B; Department of Pediatrics Maastricht University Medical Centre Maastricht The Netherlands.
  • Pai GS; Department of Clinical Genetics Maastricht University Medical Centre Maastricht The Netherlands.
  • Timson DJ; Medical University of South Carolina Children's Health, Division of Genetics Charleston South Carolina USA.
  • Rubio-Gozalbo ME; School of Pharmacy and Biomolecular Sciences University of Brighton Brighton UK.
  • Berry GT; Department of Pediatrics Maastricht University Medical Centre Maastricht The Netherlands.
JIMD Rep ; 59(1): 104-109, 2021 May.
Article em En | MEDLINE | ID: mdl-33977035
Galactokinase deficiency is an inborn error of carbohydrate metabolism due to a block in the formation of galactose-1-phosphate from galactose. Although the association of galactokinase deficiency with formation of cataracts is well established, the extent of the clinical phenotype is still under investigation. We describe a 6-year-old female who was diagnosed with galactokinase deficiency due to cataract formation when she was 10 months of age and initially started on galactose-restricted diet at that time for 5 months. She developed gait abnormality at 4 years of age. Breath tests via measurement of 13C isotope in exhaled carbon dioxide following 13C-labeled galactose administration at carbon-1 and carbon-2 positions revealed oxidation rates within the normal range. The results in this patient strikingly contrast with the results of another patient with GALK1 deficiency that underwent breath testing with [1-14C]-galactose and [2-14C]-galactose. Extension of in vivo breath tests to other galactokinase patients is needed to better understand the pathophysiology of this disease.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JIMD Rep Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JIMD Rep Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos